Dr. Stephen LaMond - 26 Sep 2023 Form 4 Insider Report for Peak Bio, Inc.

Role
Interim Chief Executive Officer, Director
Signature
/s/ Dr. Stephen LaMond
Issuer symbol
N/A
Transactions as of
26 Sep 2023
Net transactions value
$0
Form type
4
Filing time
28 Sep 2023, 16:05:23 UTC
Previous filing
28 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PKBO Common Stock Purchase +3,000 +21% 17,250 26 Sep 2023 Direct F1
transaction PKBO Common Stock Purchase +2,600 +15% 19,850 27 Sep 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 26, 2023, Dr. Stephen LaMond purchased a total of 3,000 shares of the Company's Common Stock at prices ranging from $0.13 per share to $0.14 per share.
F2 On September 27, 2023, Dr. Stephen LaMond purchased a total of 2,600 shares of the Company's Common Stock at prices ranging from $0.13 per share to $0.14 per share.

Remarks:

Interim Chief Executive Officer